SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-048303
Filing Date
2021-07-27
Accepted
2021-07-27 17:16:07
Documents
2
Period of Report
2021-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2192
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3311
  Complete submission text file 0001209191-21-048303.txt   6865
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TCR2 THERAPEUTICS INC. 100 BINNEY STREET, SUITE 710 CAMBRIDGE MA 02142
Business Address
Olagunju Peter (Reporting) CIK: 0001875057 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38811 | Film No.: 211118650